Stručni rad - Pismo uredniku
Second primary malignancies in myeloproliferative neoplasms and the role of aspirin
Leukemia, 33 (2019), 10; 2554-2554. https://doi.org/10.1038/s41375-019-0553-2


Citirajte ovaj rad

Lucijanić, M., Skelin, M. i Kušec, R. (2019). Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. Leukemia, 33. (10), 2554-2554. doi: 10.1038/s41375-019-0553-2

Lucijanić, Marko, et al. "Second primary malignancies in myeloproliferative neoplasms and the role of aspirin." Leukemia, vol. 33, br. 10, 2019, str. 2554-2554. https://doi.org/10.1038/s41375-019-0553-2

Lucijanić, Marko, Marko Skelin i Rajko Kušec. "Second primary malignancies in myeloproliferative neoplasms and the role of aspirin." Leukemia 33, br. 10 (2019): 2554-2554. https://doi.org/10.1038/s41375-019-0553-2

Lucijanić, M., Skelin, M. i Kušec, R. (2019) 'Second primary malignancies in myeloproliferative neoplasms and the role of aspirin', Leukemia, 33(10), str. 2554-2554. doi: 10.1038/s41375-019-0553-2

Lucijanić M, Skelin M, Kušec R. Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. Leukemia [Internet]. 21.08.2019. [pristupljeno 01.05.2021.];33(10):2554-2554. doi: 10.1038/s41375-019-0553-2

M. Lucijanić, M. Skelin i R. Kušec, "Second primary malignancies in myeloproliferative neoplasms and the role of aspirin", Leukemia, vol. 33, br. 10, str. 2554-2554, Kolovoz 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:646020. [Citirano: 01.05.2021.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.